Professor of Pediatrics (University of Colorado), Section Head (Pediatric Nephrology) and Medical Director of Kidney Transplantation (Childrens' Hospital Colorado)
Pediatric Nephrology
Dr. Jens Goebel, MD
|
|
Give Review
Jens Goebel is an expert in the field of Pediatric Nephrology. He has 2 awards "Regional Top Doctor" and "Fellow (FAAP)". Jens Goebel is a published doctor and has 49 publications published. The lastest was: 'The Noninvasive Urinary Polyomavirus Haufen Test Predicts BK Virus Nephropathy in Children After Hematopoietic Cell Transplantation: A Pilot Study.' Jens Goebel accepts Medicare.
Publications
- Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.
- The Noninvasive Urinary Polyomavirus Haufen Test Predicts BK Virus Nephropathy in Children After Hematopoietic Cell Transplantation: A Pilot Study.
- Hyponatremia, hypo-osmolality, and seizures in children early post-Kidney transplant.
- The impact of Disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study.
- End stage renal disease and Kidney transplant in patients with anorectal malformation: is there an alternative route?
- Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients.
- A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
- Prevalence and predictors of aortic dilation as a novel cardiovascular complication in children with end-stage renal Disease.
- Antibodies to BK virus in children prior to allogeneic hematopoietic cell transplant.
- Gaining the Patient Reported Outcomes Measurement Information System (PROMIS) perspective in chronic Kidney disease: a Midwest Pediatric Nephrology Consortium study.
- Estimated versus measured glomerular filtration rate in children prior to hematopoietic cell transplantation.
- Refined diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a prospective study in children and young adults.
- Population pharmacokinetic-pharmacodynamic modeling of mycophenolic acid in pediatric Renal transplant recipients in the early post-transplant period.
- Protective immunity and use of bortezomib for antibody-mediated rejection in a pediatric Kidney transplant recipient.
- The Effects of Unbound Mycophenolic Acid (MPA) on Inosine Monophosphate Dehydrogenase (IMPDH) Inhibition in Pediatric Kidney Transplant Patients.
- Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
- Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for Kidney transplant injury.
- Focal segmental glomerulosclerosis in children: multivariate analysis indicates that donor type does not alter recurrence risk.
- The Impact of Short Stature on Health-Related Quality of Life in Children with Chronic Kidney Disease.
- BK Viremia Precedes Hemorrhagic Cystitis in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
- Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
- Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.
- Reliable individualized monitoring improves cholesterol control in Kidney transplant recipients.
- Gaining the PROMIS perspective from children with Nephrotic syndrome: a Midwest pediatric nephrology consortium study.
- Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic Nephrotic syndrome in children.
- Outcomes of steroid-avoidance protocols in pediatric Kidney transplant recipients.
- Differing Effects of Rapamycin or Calcineurin Inhibitor on T-Regulatory Cells in Pediatric Liver and Kidney Transplant Recipients.
- UGT1A9, UGT2B7, and MRP2 Genotypes Can Predict Mycophenolic Acid Pharmacokinetic Variability in Pediatric Kidney Transplant Recipients.
- Should recipients with obstructive uropathy undergo close surveillance for BK virus infection post-transplant?
- Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?
- Cystatin C-estimated glomerular filtration rate in pediatric autologous hematopoietic stem cell transplantation.
- Creating a monster: non-adherence underlying late transplant rejection.
- System for integrated adherence monitoring: real-time non-adherence risk assessment in pediatric Kidney transplantation.
- The impact of sirolimus on sex hormones in male adolescent Kidney recipients.
- Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after Kidney transplantation.
- Reliability of resting blood pressure measurement and classification using an oscillometric device in children with chronic Kidney disease.
- Psychosocial Assessment Tool 2.0_General: validity of a psychosocial risk screener in a pediatric Kidney transplant sample.
- Blood, and Not Urine, BK Viral Load Predicts Renal Outcome in Children with Hemorrhagic Cystitis following Hematopoietic Stem Cell Transplantation.
- Intensive hemodialysis for cardiomyopathy associated with end-stage renal Disease.
- Small vessels, big trouble in the Kidneys and beyond: hematopoietic stem cell transplant associated-thrombotic microangiopathy.
- Family strategies for achieving medication adherence in pediatric Kidney transplantation.
- Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in Renal transplantation.
- Efficacy and flexibility impact perceived adherence barriers in pediatric Kidney post-transplantation.
- Interaction between tacrolimus and intravenous nicardipine in the treatment of post-Kidney transplant hypertension at pediatric hospitals.
- BK virus Nephropathy in a pediatric autologous stem-cell transplant recipient.
- The evolution of population pharmacokinetic models to describe the enterohepatic recycling of mycophenolic acid in solid organ transplantation and autoimmune Disease.
- UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric Kidney transplant recipients.
- Current Kidney allocation rules and their impact on a pediatric transplant center.
Schools
RuprechtKarlsUniversitaet Heidelberg Medizinische Gesamtfakultat
University South Ala Med Center
Tulane University Med Center
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acute Kidney Failure
- Calcium Metabolism Disorders
- Chronic Glomerulonephritis
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Pediatric Nephrology
Accepted Insurances
Awards
- Regional Top Doctor
- Fellow (FAAP)
Education
-
Tulane University -
University of South Alabama -
Ruprecht Karl University Faculty of Medicine
Drug Facts
| NPI NUMBER | 1144246760 | |
| NPPES Provider LastName | GOEBEL | |
| NPPES Provider FirstName | JENS | |
| NPPES Provider ZIPCode | 452293039 | |
| NPPES Provider State | OH | |
| Specialty Description | Nephrology | |
| Total Claim Count | 67.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144246760 |
| Last Name Of The Provider | GOEBEL |
| First Name Of The Provider | JENS |
| View All |
Similar Doctors
|
|
Dr. Charles D. Varnell Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prasad Devarajan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David K. Hooper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donna J. Claes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth C. Jackson, MD |
|
|
Dr. Ahmad Kaddourah, MD |
|
|
Dr. Rene G. Vandevoorde III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark M. Mitsnefes, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Edward J. Nehus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Latawnya D. Pleasant-Griffin, MD |